Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc XS3447690879
100.00
USD
0.00
USD
0.00
%
21.8.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 100.00 USD | USD | % |
|---|
| Vortag | USD | Datum | 21.08.2026 |
Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Aave ETP | CH1135202120 | 45.78% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 34.83% | |
| 21Shares Stellar ETP | CH1109575535 | 29.57% | |
| 21shares Morpho ETP | CH1506167027 | 24.77% | |
| 21Shares Pyth Network ETP | CH1396389939 | 23.35% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 14.51% | |
| 21Shares Injective Staking ETP | CH1360612134 | 7.43% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | 0.71% | |
| 21Shares Jupiter ETP | CH1480821383 | -0.24% | |
| 21Shares Maple Finance ETP | CH1495416989 | -3.57% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 186.92% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 74.32% | |
| 21Shares Injective Staking ETP | CH1360612134 | 71.26% | |
| 21Shares Ondo ETP | CH1396389921 | 35.80% | |
| 21Shares Jupiter ETP | CH1480821383 | 35.08% | |
| 21Shares Pendle ETP | CH1495416997 | 32.34% | |
| 21shares Morpho ETP | CH1506167027 | 32.24% | |
| 21Shares Bittensor ETP | CH1495416971 | 28.74% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | 23.65% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 17.19% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 14.57% | |
| 21Shares Binance BNB ETP | CH0496454155 | -21.81% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -23.17% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -29.63% | |
| 21Shares Bitcoin ETP | CH0454664001 | -30.60% | |
| 21Shares Injective Staking ETP | CH1360612134 | -58.70% | |
| 21Shares Dogecoin ETP | CH1431521033 | -60.56% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -62.34% | |
| 21Shares XDC Network ETP | CH1464217285 | -64.62% | |
| 21Shares Sui Staking ETP | CH1360612159 | -77.52% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 135.37% | |
| 21Shares Stellar ETP | CH1109575535 | 83.15% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 68.67% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 54.47% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 29.22% | |
| 21Shares Sui Staking ETP | CH1360612159 | -14.86% | |
| 21Shares Injective Staking ETP | CH1360612134 | -73.91% |
Fundamentaldaten
| Valor | |
| ISIN | XS3447690879 |
| Emittent | ETPCAP2 Designated Activity Company |
| Aufgelegt in | Ireland |
| Auflagedatum | 24.07.2026 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 25.08.2026 |
Anlagepolitik
So investiert der Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc: The objective of this strategy is to achieve long-term capital appreciation by investing primarily in securities that track the largest U.S. stock indexes. The strategy seeks to benefit mainly from the growth potential of leading technology companies, leveraging their innovation, market leadership, and strong financial performance.
ETP Performance: Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |